Tetrindole
Tetrindole was a drug candidate that functions by reversibly inhibitingmonoamine oxidase A; it was first synthesized in Moscow in the early 1990s.[1] Tetrindole is similar in its chemical structure to pirlindole (Pyrazidol), and metralindole.[2]
See also
References
- ↑Medvedev AE, Kirkel AA, Kamyshanskaya NS, Moskvitina TA, Axenova LN, Gorkin VZ, et al. (January 1994). "Monoamine oxidase inhibition by novel antidepressant tetrindole". Biochemical Pharmacology. 47 (2): 303–8. doi:10.1016/0006-2952(94)90021-3. PMID 8304974.
- ↑Ramsay RR, Gravestock MB (March 2003). "Monoamine oxidases: to inhibit or not to inhibit". Mini Reviews in Medicinal Chemistry. 3 (2): 129–36. doi:10.2174/1389557033405287. PMID 12570845.
Categories:
- Drugs not assigned an ATC code
- Carbazoles
- Reversible inhibitors of MAO-A
- Abandoned drugs
- Monoamine oxidase inhibitors
- Russian drugs
- Cyclohexyl compounds
- Substances discovered in the 1990s
- Nervous system drug stubs